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Abstract
Objectives The objective of this study is to estimate the overall prevalence of peri-implantitis (PI) and the effect of different study
designs, function times, and implant surfaces on prevalence rate reported by the studies adhering to the case definition of Sanz &
Chapple 2012.
Material and methods Following electronic and manual searches of the literature published up to February 2016, data were
extracted from the studies fitting the study criteria. Meta-analysis was performed for estimation of overall prevalence of PI while
the effects of the study design, function time, and implant surface type on prevalence rate were investigated usingmeta-regression
method.
Results Twenty-nine articles were included in this study. The prevalence rate in all subset meta-analyses was always higher at
patient level when compared to the prevalence rate at the implant level. Prevalence of PI was 18.5% at the patient level and 12.8%
at the implant level. Meta-regression analysis did not identify any association for different study designs and function times while
it was demonstrated the significant association between moderately rough surfaces with lower prevalence rate of PI (p = 0.011).
Conclusions The prevalence rate of PI remains highly variable even following restriction to the clinical case definition and it
seems to be affected by local factors such as implant surface characteristics. The identification of adjuvant diagnostic markers
seems necessary for more accurate disease classification.
Clinical relevance The occurrence of PI is affected by local factors such as implant surface characteristics hence the careful
assessment of the local factors should be performed within treatment planning.
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Introduction
Peri-implantitis is a major complication of dental implants and
the first cause of implant failure [1, 2]. Briefly stated, the
knowledge and clinical protocols were initially simply
translated from periodontology to the implant dentistry while
the recent implant research reveals different physiopathologi-
cal features between periodontal and peri-implant tissues. It is
proposed that histological specificities and implant-related
factors contribute to the more complex physiology and
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pathology around dental implants compared to natural denti-
tion [3, 4]. From a clinical point of view, recent studies indi-
cate that standard clinical parameters provide decreased diag-
nostic value on implants compared to teeth, while the treat-
ment of peri-implant diseases is considered unpredictable [5,
6]. Regarding peri-implant mucositis considered as a precur-
sor of peri-implantitis and pathological counterpart of gingi-
vitis on implants [7], data have failed to show disease resolu-
tion following any of non-surgical protocols applied similarly
as for the treatment of peri-implantitis [8]. For these reasons,
peri-implant diseases were recently defined as important dis-
ease entities as a result of their high prevalence and the lack of
a standard treatment protocol [6, 9].
Initial step in assessment of every pathology is evaluation
of the epidemiological characteristics of the disease [10] hav-
ing as goal to estimate how often disease occurs and why.
Epidemiological information is further used to evaluate and
improve existing preventive strategies for respective disease
and is usually implemented in concepts for managing the af-
fected population. Disease prevalence being a fundamental
epidemiological parameter was inconsistently reported for
peri-implantitis and considerably varied among studies with
more than 50% variation [11]. Therefore, the study was per-
formed to assess the quality of reporting on prevalence of peri-
implant diseases [12]. The conclusion ensued that quality of
reporting needs improvement emphasizing the use of strict
case definition as an imperative priority for minimizing
inter-study heterogeneity. Related to that, a case definition of
peri-implantitis was proposed by Sanz & Chapple on the
forthcoming 8th European Workshop of Periodontology
(EWOP) [13, 14]. Following that, the same group of authors
who provided guidelines for improvement of reporting in ep-
idemiological studies performed a meta-analysis [11] using
newly proposed case definition and reported a prevalence of
peri-implantitis of 22% at the patient level. The authors also
investigated factors in cause of inter-study heterogeneity and
demonstrated positive effect of function time on peri-
implantitis prevalence [11]. Within implications for the future
research, it was proposed the application of consistent case
definitions and assessment of additional factors in possible
cause of inter-study heterogeneity.
The proposed case definition of peri-implantitis [13, 14]
refers to use of clinical endpoints in conjunction with manda-
tory radiological proof of changes of crestal bone level or bone
loss of ≥ 2 mm from the expected marginal bone level follow-
ing initial remodeling. Such insistence on strict proof of bone
loss also indicates the limitation of clinical parameters in im-
plant diagnostics. The numerous host and implant-related fac-
tors interfere with periodontal clinical parameters on implants
subsequently decreasing their respective diagnostic value [15,
16].Moreover, the interface between implant surface and peri-
implant infection is currently considered an independent fac-
tor in pathogenesis of peri-implantitis [16, 17]. In addition to
that, the insufficient surface decontamination was proposed as
a main culprit for incomplete resolution of peri-implant in-
flammation following treatment [9] and is considered the lead-
ing cause for disease recurrence.
Thus, the objectives of this systematic review and meta-
analysis were to estimate the overall prevalence of peri-
implantitis and to determine the effect of different study de-
signs, function times, and implant surfaces on reported prev-
alence of peri-implantitis by assessing the studies using the
referent case definition proposed by Sanz & Chapple [13, 14].
Material and methods
Study protocol
This systematic review and meta-analysis comply with the
PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) [18] and the MECIR guidelines
for Cochrane intervention reviews [19].
Focused questions
& What is the frequency of peri-implantitis according to a
case definition previously defined?
& Do certain factors/characteristics (i.e., study design, im-
plant topography or function time) impact upon peri-
implantitis frequency?
PECO question (population, exposure, comparison,
outcome measures) [20]
& Population: patients wearing dental implants for restora-
tion of oral function in completely or partially edentulous,
mandibular or maxillary dental arches.
& Exposure: peri-implant disease diagnosed under a clinical
and radiographic examination and adhered to a previously
described definition
& Comparison: different implant surfaces, function times,
and study designs
& Outcome measures: frequency of peri-implantitis at
patient/implant level
Definition of peri-implantitis
Based upon Sanz & Chapple [13, 14], peri-implantitis was
defined as the presence of bone loss ≥ 2 mm, positive bleeding
on probing and probing depth ≥ 5mm, and/or concomitant
probing deepening compared to the radiograph taken at the
time of prosthetic placement.
Inclusion criteria were as follows:
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& Studies reporting the prevalence of peri-implantitis and
adhering to the case definition according to Sanz &
Chapple [13, 14]
& Studies reporting on at least 20 participants
& Randomized clinical trials (RCT),
& Prospective and retrospective cohort studies,
& Case-control and
& Cross-sectional studies
In humans, reporting the prevalence of peri-implantitis at
implant and/or patient level was considered for this systematic
review without language or date of publication restriction
reporting ≥ 20 participants were taken included for the
qualitative/quantitative analysis.
Exclusion criteria were studies reporting on the outcomes
as follows:
& Exclusively from populations with specific biological
characteristics (such as periodontally compromised pa-
tients or patients with systemic diseases recognized to af-
fect peri-implant condition)
& Exclusively from populations undergoing specific surgical
or prosthodontic protocols (such as immediate implant
placement, flapless implant placement, etc.)
& Studies with blade and mini (≤ 3 mm diameter) implants.
Search strategy
A search of the Web of Science (Science Citation Index),
U.S. National Institutes of Health free digital archives of
biomedical and life sciences journal literature (PubMed),
The Cochrane Library of the Cochrane Collaboration
(CENTRAL) as well as a hand search were conducted to
identify articles potentially relevant for the review.
Additionally, according to the AMSTAR (http://amstar.ca/
index.php) checklist, the Grey Literature Database was
screened at the New York Academy of Medicine Grey
Literature Report in order to find possible unpublished
papers. The search included articles accepted for
publication up to February 2016. The following key
words were used for that purpose:
(((((TOPIC:(dental implants) OR MeSH HEADING:exp.:
(Dental Implantation)OR MeSH HEADING:exp: (Dental
Implants)) AND TOPIC:(periimplantitis)) OR (TOPIC:
(peri-implantitis) OR MeSH HEADING:(Peri-Implantitis)))
OR TOPIC: (peri-implantitis prevalence)) OR TOPIC:(peri-
implantitis incidence)) OR((TOPIC: (peri-implantitis) OR
MeSH HEADING:exp: (Peri-Implantitis))AND (TOPIC:
( e p i d e m i o l o g y ) O RM e SH H EAD I N G : e x p :
(Epidemiology)OR MeSH HEADING:exp:(Community
Health Services)))
Timespan was not limited although the included papers
were published after 2000th.
The manual search was conducted to search the periodon-
tology and implantology-related journals published in the last
5 years (February 2011–February 2016) including the follow-
ing: Journal of Dental Research, Clinical Oral Investigations,
Journal of Cl in ica l Per iodonto logy, Journal of
Periodontology, Journal of Oral and Maxillofacial Implants,
Clinical Oral Implants Research, Clinical Implant Dentistry
and Related Research, The International Journal of
Periodontics & Restorative Dentistry and Archives of Oral
Biology. The bibliography of candidate papers was also
searched.
Quality assessment
Quality assurance was developed according to Khan et al. [21]
via independent screening by two reviewers (M.R and P.G-
M.), resolution of disagreement by consensus, discarding of
the studies in cases when consensus was not achieved and data
extraction in duplicate.
Data extraction and synthesis
Two independent reviewers (M.R. and P.G-M.) performed
initial searches and analyzed titles and abstracts in the
first stage screening to discard irrelevant articles.
Subsequently, the full-texts of the potentially eligible ar-
ticles were reviewed to assess whether the studies fit the
selected inclusion criteria. Any disagreement regarding
eligibility of the articles was individually resolved be-
tween the reviewers. Data were collected into evidence
tables when the following parameters were scored: (1)
case definition, (2) study design, (3) function time, (4)
sample size, (5) prevalence of peri-implantitis, (6) implant
brand, (7) implant surface type, and (8) additional obser-
vations related to peri-implantitis prevalence.
Synthesis of the data was performed from evidence tables
when the studies reporting on common parameters were iden-
tified and selected for meta-analysis and meta-regression
analysis.
Data analysis
The OpenMetaAnalyst [22] software was used to estimate the
prevalence rate of peri-implantitis and the potential effects of
the different function time, study design, and implant surfaces
on the prevalence.
The meta-regression analyses (random effects model)
with the heterogeneity evaluation obtained from the
inverse-variance fixed-effect model [22] was used to esti-
mate the effect of different study designs, implant sur-
faces, and function times on prevalence of peri-
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implantitis while the p value of the covariate coefficient
was evaluated using the 0.05 as a level of significance. In
brief, the calculation was performed according to
DerSimonian-Laird random effects pooling method [23]






the heterogeneity of effect size (I2) was calculated using
I2 = (Q − (k − 1))/Q*10 formula. The heterogeneity of ef-
fect size (I2) represents a measure of inter-study heteroge-
neity, while < 25%, 25–75%, and 75% indicate low, mod-
erate, or high degree of inter-study heterogeneity, respec-
tively [24, 25].
To assess the effect of different cofactors on prevalence
rate, the studies were classified as follows:
& Effect of study design: prospective, retrospective, and
cross-sectional study design
& Effect of function time: < 5 years, 5–10 years, and
>10 years of function time
& Effect of different implant surface: minimally, moderately,
and rough implant surfaces [26]. For this analysis, only the
studies reporting exact prevalence by each implant system
including the number of initial and affected implants were
taken into account.
Due to observed inter-study heterogeneity in reported
prevalence rate at the patient and implant level, the meta-
analyses were performed at patient and implant level in-
dependently, in order to comprehensively examine report-
ed evidence. Results were expressed as Forest plots with
weighted mean values and 95% confidence intervals (CI)
while the heterogeneity among the studies was expressed
using Q statistics and I2.
Results
Screening process
The flow chart of search process is depicted in the Fig. 1.
The initial search yielded 1214 articles using electronic
searches. After title screening, 193 articles were consid-
ered as potentially eligible while additional 5 articles were
identified using hand searches. This resulted in a final
number of 198 potentially eligible papers. After abstract
reviewing, the full-text analysis of 35 potentially eligible
articles was performed. A final review resulted in the se-
lection of 29 articles [27–55] considered as eligible for the
purpose of this study (Table 1.). The k value for inter-
reviewer agreement for study inclusion was 0.91 for titles
and abstracts and 1.00 for full-text articles indicating
strong agreement.
General observations
Despite the strict restriction to the case definition, the
high rate inconsistency between the studies remained
and counted 98.53% for reporting on implant level and
98.3% for reporting at the patient level. In addition to
that, the similar high heterogeneity remained following
restriction for investigated cofactors as well. Regarding
expression of the prevalence rate, it was observed
mismatching in number of investigated implants and
number of patients in all investigated studies, while
the prevalence rate in all meta-analyses was always
higher at the patient level when compared to the im-
plant level.
Potentially eligible articles identified 





Articles included in the study
n=29
Articles identified using hand search
n=5

































Articles Excluded following Abstract Screening n=163
Reasons for exclusion:
• Review articles: n=33
• Peri-implantitis treatment outcomes: n=46
• Periodontally/Systemically compromised & Smokers: n=21
• Specific prosthetic/surgical/ maintenance protocols n=57
• Risk factors n=6
Excluded articles n=6
Reason for exclusion:
Incomplete adhering to the case
definition of peri-implantitis
(lack or use of different
criteria):
• Bra gger et al. 2001, 2005;
• Schmidlin et al. 2010; 
• Rinke et al. 2011; 
• Casado et al. 2013; 
• Ostman et al. 2012 
k =0.91 
Fig. 1 Flowchart of the search
process
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Prevalence of peri-implantitis
The overall prevalence of peri-implantitis was estimated using
meta-analysis (Fig. 2.) at the implant (A) and patient level (B)
independently. Twenty-four studies reported on prevalence at
the implant level [27–32, 34–38, 40–46, 49–53, 55] ranging
between 0.2 and 63% with estimated prevalence of peri-
12.8% at the implant level. Moreover, 22 studies reported on
peri-implantitis prevalence at the patient level [29–44, 46–48,
50, 54, 55] ranging between 1 and 46% with estimated prev-
alence of 18.5% at the patient level.
Effect of study design on prevalence
of peri-implantitis
Meta-analyses were performed to assess peri-implantitis prev-
alence between 7 cross-sectional, 10 prospective, and 7 retro-
spective studies at the implant level as well as 6 cross-section-
al, 6 prospective, and 10 retrospective studies at the patient
level (Fig. 3). There was a common observation at the implant
and patient level of lower prevalence rate in prospective stud-
ies (7.6 and 9.3%, respectively), a higher prevalence rate in
retrospective studies (18.5 and 23.4%, respectively), while
reported prevalence rate for cross-sectional studies was in
the middle (14.5 and 18.6%, respectively). Despite clear dif-
ferences, meta-regression analysis did not confirm any signif-
icant effect of different study designs on reported prevalence.
Effect of implant function period on prevalence
of peri-implantitis
The effect of function time on peri-implantitis prevalence was
estimated in the 7 (at the implant level)/9 (at the patient level)
studies for the 5–10-year timeframe as well as for the 13 (at
the implant level)/11 (at the patient level) studies for function
time of 10+ years (Fig. 4.). There was one single study
reporting the prevalence rate for the function period less than
5 years [27] regularly listed with other studies but was not
considered for quantitative analysis. Prevalence rates at the
implant level were relatively similar between investigated pe-
riods, while the rates at the patient level were slightly higher
for the 10+ period when compared to the mean loading period.
Even though, the meta-regression analysis did not demon-
strate any significant effect of function time on the prevalence
of peri-implantitis.
Effect of the different implant surfaces on prevalence
of peri-implantitis
The number of the studies reporting prevalence by implant
surfaces was twofold lower at the patient level (n = 12) com-
pared to studies reporting at the implant level (n = 25)
(Fig. 5.). It was observed about threefold lower prevalence
for moderately rough when compared to the minimal and
rough implant surfaces at both implant and patient level,
counting 5.4 and 5.9% prevalence rate, respectively. The
meta-regression analysis confirmed the association of moder-
ately rough implant surfaces with lower prevalence of peri-
implantitis (p = 0.011).
Discussion
The present meta-analysis estimated similar peri-implantitis
prevalence of 12.8% at the implant level and 18.5% at the
patient level. Despite the strict inclusion criterion regarding
proposed case definition of peri-implantitis [13, 14], the high
rate inconsistence of about 98% persisted between investigat-
ed studies. Meta-regression analyses showed the positive as-
sociation between implants with moderately rough implant
surfaces and lower prevalence of peri-implantitis, while the
Fig. 2 Overall prevalence of peri-implantitis at patient (a) and implant (b) level
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different study designs and function times did not demonstrate
any significant effect on prevalence rate of peri-implantitis.
Nowadays, great efforts are invested in dental implant re-
search to systemize reported knowledge and increase the util-
ity of reported finings, frequently decreased due to inter-study
heterogeneity. Peri-implantitis represents the typical example
for that since discordance in disease definition among pub-
lished studies makes impossible estimation of the elementary
epidemiological parameters such as prevalence.
Motivated by this, the present study was designed to follow
the state-of-the-art trends on peri-implantitis regarding both
methodological and clinical recommendations, to ensure the
quality and reproducibility of the evidence that would contrib-
ute in resolution of the increasing peri-implantitis
problematics.
To do so, the referent case definition of peri-implantitis by
Sanz & Chapple [13, 14] represented the strict inclusion cri-
terion while the meta-analysis reported by Derks & Tomasi
[11] was regarded as a state-of-the-art work. Finally, the
present research was carefully designed to comprehensively
review the published literature and retrieve as much as possi-
ble data from the filtered study pool.
Regarding prevalence rate, the estimated prevalence of
18.5% was just slightly lower than previously reported 22%
[11], while the positive relation between implant function time
and prevalence of peri-implantitis was not confirmed in the
here present study.
Although the previously reported [11] and the present
study were similar by attempting to estimate the prevalence
of peri-implantitis, respective study objectives and experimen-
tal designs were differently defined starting with a fact that
present study focused strictly on peri-implantitis. The major
tendency in the here present study was not only to estimate the
prevalence of peri-implantitis, but to comprehensively exam-
ine reported literature in order to disclose potential factors in
cause of such high inter-study inconsistence. From a clinical
standpoint, identification of such factors would facilitate the
identification of potentially novel susceptibility factors
Fig. 4 Prevalence of peri-implantitis in relation to the function period at patient (a) and implant (b) level
Fig. 3 Prevalence of peri-implantitis in relation to performed study design in reported studies at patient (a) and implant (b) level
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associated with insufficiently resolved pathological pattern of
peri-implantitis. Moreover, the minimal sample size in the
present study was set significantly lower compared to the
> 100 subjects required in the previous study, since it is rec-
ommended within guidelines for meta-analyses that studies
seeking to identify factors of inter-study heterogeneity should
be as much inclusive as possible without insisting on great
sample size [56]. Such approach has as main advantage the
possibility of performing a meta-analysis that enables integra-
tion of the findings from independent studies thus increasing
the statistical power from the individual studies to compensate
for the small sample sizes in the clinical trials. [56] However,
70% of the studies from the study pool reported on more than
100 participants and only three studies reported on less than
50 patients while the estimated prevalence was similar to the
prevalence reported in the previous study indicating the com-
parable results with study applying higher sample size thresh-
old. Furthermore, as peri-implantitis is considered a site-
specific pathology, in the present study prevalence rate was
additionally estimated at the implant level as it is considered
that ratio between prevalence at the patient and implant level
might provide important insights [57]. Related to that, only
two studies had approximately equal numbers of participants
and implants, while a vast majority of the studies had 2–5
times more implants than participants. This finding together
with the higher prevalence found at patient level compared to
the implant level indicates that not all implants were affected
by peri-implantitis and underlines the importance of assessing
the outcomes at the implant level as well. Additionally, this
finding points out the site-specific nature of peri-implantitis
[58] and important role of the local etiological factors in dis-
ease pathogenesis.
Regarding different study designs, the lowest prevalence
rate was observed in prospective studies that were almost
threefold lower when compared to the retrospective studies
and two times lower than in cross-sectional studies. A possible
explanation for this trend is that patients participating in pro-
spective studies are generally enrolled in well-controlled peri-
implant maintenance therapy (PIMT) program. In addition to
that, a recent systematic review has demonstrated that strict
PIMT every 5–6 months may prevent the incidence of peri-
implant diseases by approximately three times [59].
Moreover, the effect of different implant surfaces on peri-
implantitis prevalence was investigated since it was proposed
that surface topography and chemistry might increase the sus-
ceptibility for peri-implantitis [17, 60]. The meta-analysis es-
timated threefold lower prevalence for moderately rough
when compared to the minimal and rough implant surfaces
while the meta-regression confirmed the association of mod-
erately rough implant surfaces with lower prevalence of peri-
implantitis. Regarding moderately rough implant surfaces, the
studies fitting the study criteria reported on Bbig five^ implant
systems including TiUnite, Sandblast acid etching (SLA),
Osseospeed, Osseotite, and Friadent [26]. However, it should
be considered that follow-up period for the implants with
rough and minimally rough implant surfaces was generally
higher than for the modern implants with moderately rough
surface.
Besides estimating the potential impact of three factors on
prevalence of peri-implantitis, the studies reporting exclusive-
ly on the population affected by the established risk factors for
peri-implantitis such as periodontitis, smoking, or diabetes
mellitus represented exclusion criteria in the present study in
order to avoid a false increase in the prevalence rate. However,
it should be considered that exclusion of the studies exclusive-
ly reporting on this risk affected population did not disclose
exclusion of the individuals affected by the same risk factors
within included studies reporting on general population.
Inconsistently reported prevalence rate represents a com-
mon finding for the multifactorial diseases and meta-analysis
Fig. 5 Prevalence of peri-implantitis in relation to the implant surface at patient (a) and implant (b) level
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is an analytical instrument of choice for resolving such prob-
lem. The main advantage of meta-analysis is the ability to
consolidate the findings from the unlimited number of small
clinical trials thus increasing the statistical power of small
sample sizes from the individual studies. Such approach si-
multaneously enables comprehensive assessment of large-
scale parameters and identification of the new intrinsic
pathogenetical factors in cause of inter-study heterogeneity.
However, besides evident advantage in strengthening evi-
dence, data pooling within meta-analyses is susceptible to
the numerous biases mostly due to different methodological
approaches among studies. Moreover, due to mandatory fo-
cusing on the target inclusion criteria, many important specific
factors remain disregarded bringing another important bias for
this methodological approach. In case of peri-implantitis prev-
alence, it was already emphasized that random sample would
provide the most reliable results [11] while this kind of studies
represented minority of the study sample. Additionally, many
biological and implant-related factors are reported to affect
peri-implant profile in health and disease why appropriate
diagnosis of peri-implant conditions and their respective clas-
sification are currently challenged. In that regard, consider-
ation of only target group of factors within inclusion criteria
might be considered another source of bias and this should be
considered when interpreting the outcomes of the meta-anal-
yses. Finally, it should be kept in mind that the most frequently
encountered risk when analyzing such a big data pool using
meta-analysis method is related to the missing studies and
associated data which might substantially influence the study
outcomes.
When considering results as a whole, mismatching in prev-
alence rate at the implant and patient level together with sig-
nificant effect of implant surface on prevalence rate confirms
site-specific nature of peri-implantitis. Future research should
attempt to establish critical thresholds for the time and volume
of the bone resorption to distinguish physiological bone
remodelation and progressive bone loss associated with peri-
implantitis. The assessment of adjuvant objectively measur-
able parameters such as biomarkers might contribute to a
faster and more accurate diagnosis of the disease as previously
suggested [61–63].
Conclusion
Within limitations of the present study, peri-implantitis affects
about 18.5% patients and 12.8% implants while the implants
with moderately rough surface seems to be associated with
lower prevalence rate.
Persistence of substantial inter-study heterogeneity follow-
ing restriction to the clinical case definition indicates the ne-
cessity for identification of adjuvant diagnostic markers that
would enable a more accurate disease diagnosis. Due to site-
specific nature of the peri-implantitis, future studies should
focus on local cofactors possibly playing in inter-study incon-
sistence, while the implication of local factors should be care-
fully considered during treatment planning.
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